Cord blood transplants supported by co-infusion of mobilized hematopoietic stem cells from a third-party donor. - Wikidata - wikimedia - TriplyDB

Cord blood transplants supported by co-infusion of mobilized hematopoietic stem cells from a third-party donor.

Cord blood transplants supported by co-infusion of mobilized hematopoietic stem cells from a third-party donor.

http://www.wikidata.org/entity/Q44885226

about

Cord blood graft engineering Effect of donor-recipient HLA matching at HLA A, B, C, and DRB1 on outcomes after umbilical-cord blood transplantation for leukaemia and myelodysplastic syndrome: a retrospective analysis Quality rather than quantity: the cord blood bank dilemma.Dominant unit CD34+ cell dose predicts engraftment after double-unit cord blood transplantation and is influenced by bank practice.Transplant outcomes in acute leukemia. I.Umbilical cord blood transplantation: the first 25 years and beyond.Paroxysmal nocturnal hemoglobinuria: a single Spanish center's experience over the last 40 yr Concise review: umbilical cord blood transplantation: past, present, and future Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis Reduced-intensity conditioning with combined haploidentical and cord blood transplantation results in rapid engraftment, low GVHD, and durable remissions.Engraftment kinetics and graft failure after single umbilical cord blood transplantation using a myeloablative conditioning regimen.High Disease-Free Survival with Enhanced Protection against Relapse after Double-Unit Cord Blood Transplantation When Compared with T Cell-Depleted Unrelated Donor Transplantation in Patients with Acute Leukemia and Chronic Myelogenous Leukemia.In vivo DPP-4 inhibition to enhance engraftment of single-unit cord blood transplants in adults with hematological malignancies Umbilical cord blood transplantation supported by third-party donor cells: rationale, results, and applications.A novel reduced-intensity conditioning regimen induces a high incidence of sustained donor-derived neutrophil and platelet engraftment after double-unit cord blood transplantation.Background and future considerations for human cord blood hematopoietic cell transplantation, including economic concerns.Comparison of outcomes after HLA-matched sibling and unrelated donor transplantation for children with high-risk acute lymphoblastic leukemia.Future of cord blood for oncology uses.Cord blood transplantation in adults.Emerging concepts in haematopoietic cell transplantation.Emerging drugs for prevention of graft failure after allogeneic hematopoietic stem cell transplantation.Alternative donor transplantation--"mixing and matching": the role of combined cord blood and haplo-identical donor transplantation (haplo-cord SCT) as a treatment strategy for patients lacking standard donors?Umbilical cord blood donation: public or private?Optimal Practices in Unrelated Donor Cord Blood Transplantation for Hematologic Malignancies.Individualized conditioning regimes in cord blood transplantation: Towards improved and predictable safety and efficacy.Results of a prospective multicentre myeloablative double-unit cord blood transplantation trial in adult patients with acute leukaemia and myelodysplasia Severe infections after single umbilical cord blood transplantation in adults with or without the co-infusion of CD34+ cells from a third-party donor: results of a multicenter study from the Grupo Español de Trasplante Hematopoyético (GETH).Update on umbilical cord blood transplantation Fungal and viral infections after allogeneic hematopoietic transplantation from unrelated donors in adults: improving outcomes over time.Risk factors and options to improve engraftment in unrelated cord blood transplantation Combined cord blood and bone marrow transplantation from the same human leucocyte antigen-identical sibling donor for children with malignant and non-malignant diseases.Long-term outcome and prognostic factors of unrelated cord blood transplantation in children with haematological malignancies: a retrospective study using the Spanish Working Party for BMT in Children (GETMON) database.Myeloablative conditioning regimens with combined of haploidentical and cord blood transplantation for myelodysplastic syndrome patients.Early peripheral blood and T-cell chimerism dynamics after umbilical cord blood transplantation supported with haploidentical cells.Combination of a haploidentical SCT with an unrelated cord blood unit: a single-arm prospective study.

P2860

Q26822376-9EAC92E7-46F4-4A70-B306-62ACA0C0543D Q30424777-B9CFE8AE-FA84-42E5-9D7C-4543E7AB0B86 Q33452269-69DA23E1-95B5-4BDB-97F0-0E1B58698A22 Q33456839-E70670B6-D6CB-451F-B5C4-36354FE6FC1B Q33621502-7680E4DC-6BC8-406B-BF01-6DC2CE52DF96 Q34344669-338CFCE4-1B89-4D06-8672-5A4DBBF00D7F Q34516330-1CE2C735-09CD-4FEE-A11F-C4A3746E703A Q34601968-6431A7E2-8250-4BA3-BCC9-D5AD52B7223D Q35185685-C3C51158-C83A-426B-BCC1-23707CC78CB1 Q35608181-60D9A243-3940-4D15-8B18-96B22D93174E Q36036346-8733BB7A-68F5-4E0C-A53D-39C5E725C407 Q36622322-2DB22060-0F54-4B00-897A-81D5FBC91366 Q36715531-8C74E2AC-C6A3-4736-B61C-3A0CB95AB0BC Q36746512-F633A382-7F52-4D12-87F3-4766B9E70774 Q36905573-94B56EAD-012A-4560-A2C1-CE022043E873 Q37443125-ABA48A94-DC93-4695-9B93-B73DC4E37CE9 Q37472615-15822151-A16B-47ED-8C93-65C55C250C50 Q37607977-FFDF1BEB-1737-4050-8709-C309D0461D6C Q37607986-ED48D1BD-A190-42DE-89EC-377A416B5520 Q38013047-AF6B0850-5373-4D12-BA6C-D446B41EB5D9 Q38105635-2CE3B742-E6C2-4CF8-877B-4FC1AFFA9750 Q38350274-B47AB441-E304-44B2-BC49-07B71AA2A1A7 Q38510475-57232C7B-1CC7-4F50-A7D3-19DECA3FD6F0 Q38747929-CE2DF4FA-3965-46FC-A2B2-20BA96698F8A Q38897538-EC075701-B660-4E80-A644-579E046E2DC5 Q41411372-4FD9BADE-59A9-4185-B874-FAB49DCA88E0 Q41478754-1A3BBDF9-A807-4AA9-8DCC-E4EB76735DD2 Q41589103-165FC79B-36EF-473B-9B08-678FADDD7A21 Q41688144-10E0700D-9ED2-4A3C-A688-FB9EF8BC2468 Q42735351-742459E1-6A03-4882-970B-706E537C1FD3 Q44664430-19B92FE5-F371-438F-9485-65CFB56F5CDE Q44756831-432C458D-5959-40C4-88CA-37721DC9544D Q48616629-847B632B-250F-4876-900D-A9DC6E188C8A Q54628559-0EE02A63-93DF-448D-A035-78773E641DA0 Q54725207-2843AFC1-311A-4D35-96F9-FCC2620C0789

P2860

Cord blood transplants supported by co-infusion of mobilized hematopoietic stem cells from a third-party donor.

http://www.wikidata.org/entity/Q44885226

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh

2008年學術文章

@zh-hant

name

Cord blood transplants support ...... ells from a third-party donor.

@en

Cord blood transplants support ...... ells from a third-party donor.

@nl

type

label

Cord blood transplants support ...... ells from a third-party donor.

@en

Cord blood transplants support ...... ells from a third-party donor.

@nl

prefLabel

Cord blood transplants support ...... ells from a third-party donor.

@en

Cord blood transplants support ...... ells from a third-party donor.

@nl

P1433

Q44885226-2BE61FEC-5CCD-438B-AF9E-DCD98F517C16

P1476

Q44885226-3A969B8C-184A-49A7-96B5-F462C0E4FFF4

P2093

Q44885226-019640D6-788B-4606-8DE3-A52955889B0D

Q44885226-409B517E-7DB2-44F8-BE5C-917FE2F581E2

Q44885226-6E60FF44-5A77-482E-9151-827013E3229A

Q44885226-79BE5409-7CF9-4464-81CA-1E8720EDB204

Q44885226-7E9E9C3A-0713-41C9-9DE5-A13ABF935E28

Q44885226-9E6C6A39-D1BE-444D-984E-A072C7B8A220

Q44885226-9EE777E1-EBA7-437F-B0A1-089EDAE88506

Q44885226-9F61168F-CD35-4456-A62C-6B724B0DE8E4

Q44885226-A17E0525-5BA7-4776-9DA8-CC2743F7B688

Q44885226-B89F397E-88B8-4A0D-B90C-311D3F709CD4

P2860

Q44885226-166ABCB4-4D98-4B45-81A3-7E1C51EA1823

Q44885226-24F1F089-9667-4B05-899F-E2A4C1B284F3

Q44885226-2C80415D-2DF9-4422-BEE8-6F10F71066D1

Q44885226-35BA5342-8FD1-43FB-B479-7385235DEB8E

Q44885226-6BA3D727-BADB-4AFB-AAD1-533120FE2E2A

Q44885226-742964EA-5B73-4BD7-A8BE-BD03AEB623FE

Q44885226-840786DC-8F8A-4ACA-BF8F-B082688A1080

Q44885226-8C57CF6A-E79D-4357-8861-CD9F4864BAEE

Q44885226-90685FC6-CA63-41EF-9B40-C9006422E2D5

Q44885226-A01D078D-1F92-4955-86AF-0EBF687488EA

P2888

Q44885226-E6E3ABFA-3E27-4244-B238-C6CAE6693407

P304

Q44885226-79268C18-4C6D-4A04-AB79-841DEE85640C

P31

Q44885226-E075530B-A0FC-416E-9FCC-75022EC3720D

P356

Q44885226-237561F0-8B16-47D3-B58B-3FF548301089

P407

Q44885226-492BCCF2-F3BE-474D-BF8D-88F08D76A00E

P433

Q44885226-FCF4B047-B172-44DA-8A92-54D684A225A8

P478

Q44885226-A1D88FB3-B881-431D-9104-74D2764C9546

P577

Q44885226-EBDD0F68-545A-4AF2-BC6A-F11A447797FA

P5875

Q44885226-5BF6E55D-0165-4DAF-952E-261DFAFEB056

P6179

Q44885226-4E012C7E-58A7-4F35-80E9-4B78BC485B33

P698

Q44885226-CA307797-3A6A-4971-92A3-279CBF2B3A14

P356

P1433

Bone Marrow Transplantation

P1476

Cord blood transplants support ...... ells from a third-party donor.

@en

P2093

A de Laiglesia

http://www.w3.org/2001/XMLSchema#string

B Navarro

http://www.w3.org/2001/XMLSchema#string

C Regidor

http://www.w3.org/2001/XMLSchema#string

E Magro

http://www.w3.org/2001/XMLSchema#string

E Ojeda

http://www.w3.org/2001/XMLSchema#string

E Ruiz

http://www.w3.org/2001/XMLSchema#string

G Bautista

http://www.w3.org/2001/XMLSchema#string

I Krsnik

http://www.w3.org/2001/XMLSchema#string

I Millán

http://www.w3.org/2001/XMLSchema#string

I Sanjuán

http://www.w3.org/2001/XMLSchema#string

P2860

Estimation of failure probabilities in the presence of competing risks: new representations of old estimators.

Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease.

Natural killer cell alloreactivity for leukemia therapy.

Adult umbilical cord blood transplantation: a comprehensive review.

Expanding the role of umbilical cord blood transplantation.

A meta-analysis of unrelated donor umbilical cord blood transplantation versus unrelated donor bone marrow transplantation in adult and pediatric patients.

Reduced-intensity allogeneic transplant in patients older than 55 years: unrelated umbilical cord blood is safe and effective for patients without a matched related donor

Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning.

Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia.

Mesenchymal stem cells for graft-versus-host disease: a double edged sword?

P2888

P304

365-373

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BMT.2008.329

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

43

http://www.w3.org/2001/XMLSchema#string

P577

2008-10-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23314105

http://www.w3.org/2001/XMLSchema#string

P6179

1044121125

http://www.w3.org/2001/XMLSchema#string

P698

18850019

http://www.w3.org/2001/XMLSchema#string